CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide.
about
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsBacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism.Interactions of HIV-1 with antigen-presenting cells.Interactions between HIV-1 and mucosal cells in the female reproductive tractInduction of cytokine synthesis by flagella from gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes.A unified concept of HIV latency.COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilizationPotent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibodyCD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae.Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis.RNAi as an antiviral therapy.Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosaCell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cellsExposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.SIV vpx is essential for macrophage infection but not for development of AIDS.Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.Nef protein of human immunodeficiency virus and lipopolysaccharide induce expression of CD14 on human monocytes through differential utilization of interleukin-10.Regulation of macrophage activation and human immunodeficiency virus production by invasive Salmonella strainsTargeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.Endotoxins, cytokines, and neuroimmune networks with special reference to HIV infection.Induction of tumor necrosis factor alpha (TNF alpha) and enhancement of HIV-1 replication in the J22HL60 cell line by Mycoplasma penetrans.Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding.C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients.
P2860
Q24651506-C7ADC1D8-78E0-4DD8-8674-20B1899167F3Q27469350-311E589E-FAD0-4C12-A6BF-FFAEE6F43C7CQ33717476-125DFB7A-1E75-422E-B337-D52496D228CEQ33815410-D8708B53-BB29-4E51-92C4-ED3C6108F691Q34002084-19D4FCA2-74C8-476E-96F8-9C01A00D0F73Q34571862-BE0349F1-1712-42BE-9CA3-3ECAD548B556Q35076655-B51D54A9-2E0B-4AC1-8D0D-42F37BA77B43Q35365812-6E22A7C8-BE06-4912-8D1E-C6424B6BC96CQ35778074-1FF8EF5A-BB12-4008-853E-EA094C92DA78Q35867080-DCD77220-FA29-404E-8EF1-2CD11498D92DQ36299940-830F331A-DA9F-42FB-B568-65A129E216BAQ36363786-7DD9708C-7CCC-4C48-B10B-065B62FC8813Q36619988-2AFFD376-E6F9-410C-8B87-C5616B817925Q37385745-5841F263-6FC9-44CB-9B94-03CD208CCCE8Q37499154-46494F6E-0E98-47B9-B440-49CD3A52536BQ38358539-ED9EBE57-875A-47BF-81CB-1BD76B02CD95Q39662474-DB676FB4-C42B-4BF8-B5F7-0D9A68850E8FQ39821967-B132D419-E692-4D42-A115-81E6FB11B0A3Q39874498-4B7563F6-CF43-4C8E-B1E2-53E74CB22DB7Q40572329-32DF415F-63BC-4D73-B310-0A0B8F23FAF9Q41243417-11D5296F-C9CA-4DA8-91B4-6625BCA21D14Q41324146-965B1833-728C-4F82-9C44-F14991B3FDADQ42172842-510D10A2-C0DC-4D2C-85BE-40D9A7112F51Q45750402-BBC635A4-AA94-4492-9648-29DE6CA534F0
P2860
CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@en
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@nl
type
label
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@en
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@nl
prefLabel
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@en
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@nl
P2093
P2860
P356
P1476
CD14 is involved in control of ...... d cells by lipopolysaccharide.
@en
P2093
R J Pomerantz
S D Wright
T Seshamma
P2860
P304
P356
10.1073/PNAS.89.14.6285
P407
P577
1992-07-01T00:00:00Z